XML 61 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Operating activities    
Net income $ 142,982 $ 113,979
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 106,838 116,644
Amortization of intangible and other assets and favorable/unfavorable leases 3,216 2,935
Amortization of long-term prepaid rents 1,988 1,976
Amortization of debt issue costs 3,575 3,557
Amortization of deferred revenues, deferred lease incentives and other (6,890) (7,221)
Amortization of accumulated other comprehensive loss related to interest rate swap agreement 2,470 3,248
Fair value change in interest rate swap agreements not designated as hedges (761) (754)
Amortization of bond discount 692 633
Impairment of long-lived assets 1,472 3,601
Share based awards compensation expense 10,165 7,132
Loss on sale of assets and other 8,004 6,937
Loss on contribution and sale of digital projection systems to DCIP   1,038
Loss on early retirement of debt    4,945
Deferred lease expenses 3,327 2,910
Deferred income tax expenses 6,935 10,536
Equity in income of affiliates (9,622) (2,353)
Distributions from equity investees 4,563 4,599
Changes in assets and liabilities (4,779) 17,320
Net cash provided by operating activities 274,175 291,662
Investing activities    
Additions to theatre properties and equipment (146,527) (126,183)
Proceeds from sale of theatre properties and equipment 737 5,131
Investment in DCIP and other (1,375) (1,268)
Net cash used for investing activities (161,245) (189,278)
Financing activities    
Proceeds from stock option exercises 4 444
Payroll taxes paid as a result of restricted stock withholdings (3,263) (494)
Dividends paid to stockholders (72,236) (71,856)
Repayments of long-term debt (9,051) (164,587)
Proceeds from issuance of senior subordinated notes   200,000
Payment of debt issue costs   (4,539)
Payments on capital leases (6,958) (5,314)
Purchase of noncontrolling interest in Cinemark Chile   (1,443)
Other 39 (301)
Net cash used for financing activities (91,465) (48,090)
Effect of exchange rate changes on cash and cash equivalents (2,114) (7,896)
Increase in cash and cash equivalents 19,351 46,398
Cash and cash equivalents:    
Beginning of period 521,408 464,997
End of period 540,759 511,395
UNITED STATES
    
Investing activities    
Acquisition of theatre in U.S. (14,080)  
ARGENTINA
    
Investing activities    
Acquisition of theatre in U.S.   $ (66,958)